China's Anti-HIV Innovative Drugs Step into Africa, Debut at INTEREST 2025

Youth Subgroup Study of Ainuomiti Tablets Selected for Oral Presentation at Asia-Pacific AIDS & Co-Infections Conference

The Light of National Innovation! 144-Week Data of Ainuomiti Tablets Released

Three-Year "iStudy Program" Successfully Concluded! Chinese Data Paves the Way for National Innovation in HIV Prevention and Treatment

First Overseas GMP Certificate! Aidea Pharma Obtains GMP Certificate from Zanzibar Food and Drug Agency

Breaking News丨Aidea Pharma and Nanda Pharma Obtain IND Approval for AD108 Injection, a New Drug for Stroke Treatment

They Need to Be Seen! Domestic Innovation "Anti-HIV Twin Stars" Protect the Health of Women Living with HIV

96-Week SPRINT Study of China’s Innovative Antiretroviral Ainuomiti Tablets Featured at CROI 2025

Key Events in 2024